| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,686 |
5,414 |
$220K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,159 |
1,992 |
$121K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,715 |
1,634 |
$114K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,700 |
3,431 |
$92K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
711 |
687 |
$44K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
368 |
353 |
$6K |
| 90686 |
|
346 |
335 |
$6K |
| 93000 |
|
300 |
294 |
$4K |
| 97803 |
|
350 |
348 |
$4K |
| 81002 |
|
1,489 |
1,448 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
127 |
124 |
$2K |
| 82044 |
|
645 |
614 |
$2K |
| 82570 |
|
645 |
614 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
34 |
34 |
$2K |
| 0011A |
|
32 |
32 |
$1K |
| 0012A |
|
29 |
29 |
$1K |
| 99385 |
|
13 |
12 |
$937.21 |
| 3078F |
|
533 |
501 |
$839.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
26 |
$639.24 |
| 3074F |
|
469 |
443 |
$619.10 |
| 3079F |
|
280 |
273 |
$585.29 |
| 3077F |
|
253 |
250 |
$551.28 |
| 99454 |
|
12 |
12 |
$505.38 |
| 99457 |
|
12 |
12 |
$418.01 |
| 3044F |
|
100 |
96 |
$416.00 |
| 3075F |
|
152 |
144 |
$356.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
13 |
$153.02 |
| 3080F |
|
59 |
56 |
$89.00 |
| 1126F |
|
15 |
14 |
$1.00 |
| 1170F |
|
18 |
17 |
$1.00 |